Skip to main content
. 2022 Feb 17;197(3):293–301. doi: 10.1111/bjh.18066

FIGURE 2.

FIGURE 2

Relationship between anti‐S antibody concentration after second vaccine dose and myeloma status from clinical records and patient reported (n = 195) CR/VGPR, Complete remission/very good partial remission; PR/stable, partial remission/stable disease. Kruskal–Wallis test, p < 0.001 for myeloma patients only (excluding smouldering myeloma patients) [Colour figure can be viewed at wileyonlinelibrary.com]